Rituximab noninferior to conventional therapy in ANCA-associated vasculitis ... 2 Minute Medicine 1. At 18 months, patients with ANCA-associated vasculitis treated with one course of rituximab had similar outcomes in terms of inducing remission when compared to patients treated with conventional continuous immunosuppression therapy. 2. The overall ... Rituximab Equally Effective for Remission of Vasculitis |
